生命科学资讯

生物技术与制药领域的最新动态

最新
Roche Media Roche Media 2025-11-19

KaliVir Immunotherapeutics宣布与罗氏达成临床试验合作与供应协议,共同评估VET3-TGI联合阿特珠单抗(Tecentriq®)治疗晚期实体瘤的效果——雅虎财经报道

KaliVir Immunotherapeutics Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate VET3-TGI in Combination with Atezolizumab (Tecentriq®) in Advanced Solid Tumors - Yahoo Finance

#Immunotherapeutics Announces#Announces Clinical#Clinical Trial#Trial Collaboration#Supply Agreement